Speaker Profile

M.D., Ph.D., Leon Henri Charbonnier Endowed Chair of Pathology, Augusta University

Biography
Dr. Ravindra Kolhe is a Leon Henri Charbonnier Endowed Chair of Pathology at Augusta University and is the inaugural Associate Dean for translation research at Medical College of Georgia. He also serves as the Associate Cancer Center Director for Genomics at the Georgia Cancer Center. Currently, Kolhe leads an NCI-designated translational pathology laboratory for MATCH testing which is focused on comprehensive genomic testing in oncology. He co-founded a consortium (SEQUOIA) of 40+ clinical laboratories across the globe for the democratization of NGS testing in oncology & successfully helped multiple labs to bring NGS testing in-house. He served on the Georgia Governor’s Task Force for COVID-19 and successfully led the COVID-19 screening program for the State of Georgia during the early Pandemic. Kolhe is also a co-founder of a COVID-19 Host Genome Structural Variation Consortium and coordinated a global network of researchers who are contributing to our collective knowledge on host genome response to the SARS-CoV-2 infection and COVID-19 disease. He has led several studies, focused on adapting and validating newer technologies (NGS, RNA-seq, OGM, etc) in CLIA laboratories by establishing PLA & Z-codes and reimbursement. He has authored more than 90+ peer-reviewed publications and serves on multiple CAP committees and scientific advisory boards for numerous profit and non-profit organizations.


 Session Abstract – PMWC 2022 Silicon Valley


  • Dismantling Barriers to Biomarker Testing Through Collaboration (PANEL)
    Session Chair: Omar Perez, AstraZeneca - Nikki Martin, LUNGevity
    - Jenn Higgins, Guardant Health
    - Kamala Maddali, Deep Lens
    - Dan Rhodes, Strata Oncology
  • Health Systems Perspective: Leveraging Real-world Evidence to Improve Patient Care (PANEL)
    Session Chair: Anna Berry, Syapse
    - Mary Walters, Aurora Health
    - Haythem Y Ali, Henry Ford Health System
  • Comprehensive Profiling: Combination of Tissue and Plasma Biomarker Strategies
    Session Chair: Maggie Rougier-Chapman, Personal Genome Diagnostics (PGDx)
    - Cynthia Pointer, Genapsys
    - Ravi Kolhe, Augusta University
    - Stephen Miller, Blueprint Medicines
  • Immuno-oncology Biomarkers for Predicting Drug Efficacy
    Session Chair: Padma Sundar, Oncocyte
    - Paul Billings, Natera
    - Daniel Rhodes, Strata Oncology
  • Reimagining Oncology - Closing the Gaps between Science and Clinic (PANEL)
    Session Chair: Christian Wolfrum, Siemens Healthineers
    - Ben Gonzales, Biognosys AG
    - Debanti Sengupta, Varian
    - Rangarajan Sampath, Siemens Healthineers
    - Steven Artandi, Stanford
  • Challenges to Implementing Precision Oncology in the Community Setting (PANEL)
    Session Chair: Jerry Mitchell, Foundation Medicine
    - Erika Brown, One Cancer Place
    - Lee Schwartzberg, OneOncology
    - Vivian Lee, Patient Advocate
  • Community Hospitals Reimbursement Landscape and Modeling (PANEL)
    Session Chair: Brady Davis, Canexia Health
    - Julie Eggington, CGI (Center for Genomic Interpretation)
    - Jennifer Strickland-Reddy, Sutter Health